HEB

Satellite Sessions

May 25 | 12:30-14:00

Pfizer Pharmaceuticals Israel | May 25 | 12:30-14:00

Title: To screen or not to screen? Pros vs Cons for proactive screening in Rare & Common Heart Diseases

Click here to view session agenda.

AstraZeneca (Israel) | May 25 | 12:30-14:00

Title: From HF to CKD and everything in between

Click here to view session agenda.

Nanox AI | May 25 | 12:30-14:00

Title: The Future of Population Health – Empower Medical Imaging to Improve Patient Care

Click here to view session agenda.

May 26 | 12:30-14:00

Abbot Laboratories | May 26 | 12:30-14:00

Title: Structural Heart Therapies- Nurses and Technicians Satellite

Click here to view session agenda.

Novartis Israel | May 26 | 12:30-14:00

Title: Novel approach in LDL-C management for ASCVD and FH patients- From theory to practice

Click here to view session agenda.

Bayer Israel | May 26 | 12:30-14:00

Title: What’s next for your HF patients following a Worsening event?

Click here to view session agenda.

Novo Nordisk | May 26 | 12:30-14:00

Title: Obesity and CVD: Deciphering a complex relationship

Click here to view session agenda.

KEEP ME UPDATED

Contact

Ortra Ltd.

94 Yigal Alon St. P.O.Box 9352

Tel Aviv 6109202, Israel

Tel: +972-3-6384444

Fax: +972-3-6384455

Email: israelheart@ortra.com